Background: Intracerebral hemorrhage requires rapid mechanism‐specific treatment, yet early stroke triage relies on clinical severity scales that do not reliably distinguish hemorrhage from ischemic stroke. We assessed the feasibility of a standardized ultrafast transcranial ultrasound protocol designed to support subsequent artificial intelligence (AI)‐based intracerebral hemorrhage detection. Methods: HYPER‐AI‐SCAN (Hyper‐Acute AI‐Assisted Sonographic Cerebral Hemorrhage Assessment Network) was a single‐center prospective feasibility study with embedded exploratory AI analysis. Between March and December 2025, 102 adults with acute computed tomography (CT)‐confirmed stroke were prospectively enrolled according to trained operator availability. Primary feasibility outcomes were protocol completion, operator‐rated adequate transtemporal windows, and acquisition time. In patients with retrievable paired baseline CT, exploratory AI analyses compared CT‐only, ultrasound‐only, and cross‐modal CT‐guided ultrasound models using patient‐level area under the receiver operating characteristic curve, sensitivity, and specificity. Results: Two patients were excluded after acquisition because insonation depth was <19 cm, yielding 100 evaluable patients (33 intracerebral hemorrhage; 67 ischemic stroke). The protocol was completed in all evaluable patients; adequate transtemporal windows were identified in 87%, and median acquisition time was 22 seconds (interquartile range, 13–31). Paired baseline CT images were available in 91 patients. Mean area under the receiver operating characteristic curve was 0.86 (SD, 0.07) for the CT‐only model, 0.85 (SD, 0.14) for the ultrasound‐only model, and 0.92 (SD, 0.07) for the cross‐modal model. Conclusions: Standardized ultrafast transcranial ultrasound acquisition was feasible at the bedside in acute stroke and generated brief cine‐loops suitable for exploratory AI development. Multicenter external validation is required before diagnostic or triage application. Registration Information: Clinicaltrials.gov. Identifier: NCT07319013.
5 June 2026 in Seizure: European Journal of Epilepsy